Sumitomo Dainippon Pharma Oncology Appoints Jatin J. Shah, M.D. as Chief Medical Officer

CAMBRIDGE, Mass., Feb. 22, 2022 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage pharmaceutical company focused on resea...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Texas ,United States ,Sumitomo Dainippon Pharma ,Jatinj Shah ,Patricias Andrews ,Division Of Cancer Medicine ,University Of Texas Md Anderson Cancer Center ,Global Head Of Development ,Ohio State University ,Department Of Lymphoma Myeloma ,Prnewswire Sumitomo Dainippon Pharma Oncology Inc ,Translational Research ,Ohio State University College Of Medicine ,Dainippon Pharma Oncology ,Executive Vice President ,Chief Medical Officer ,Global Head ,Chief Executive Officer ,Sumitomo Dainippon Pharma Oncology ,Karyopharm Therapeutics ,Cancer Center ,Associate Professor ,Associate Program Director ,Malignant Hematology Fellowship ,Myeloma Clinical ,Mechanical Engineering ,Ohio State University College ,